INS and Hypoglycemia: The current data showed that 27.3% and 61.6% of patients were using insulin and sulphonylureas and were higher than a study conducted in Colombia [20] in which sulphonylureas use was found in 23.4%, and insulin in 20.7% this could in part explain the high risk of hypoglycemia in the current sample.